Financials
- Market Capitalization 1.84 B
- Employee 1 605
- Founded 2000
- CEO Asaf Danziger
- Website www.novocure.com
- Headquarter N/A
- FIGI N/A
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1977 | AXGN Axogen, Inc. - Common Stock | 38.85 USD | +0.21% | -9.99% | -11.70% | +112.99% | 2.07 B USD | ||
| 2011 | BFLY Butterfly Network, Inc. Class A Common Stock | 7.48 USD | -3.61% | +2.33% | +32.16% | +320.22% | 1.95 B USD | ||
| 2073 | UFPT UFP Technologies, Inc. - Common Stock | 240.88 USD | +4.68% | -5.15% | +2.08% | +18.54% | 1.86 B USD | ||
| 2210 | IART Integra LifeSciences Holdings Corporation - Common Stock | 18.83 USD | +2.34% | +7.97% | +6.26% | +16.81% | 1.46 B USD |
Frequently asked questions about NovoCure Limited - Ordinary Shares
What is the NovoCure Limited - Ordinary Shares stock price today?
The current price of NovoCure Limited - Ordinary Shares (NVCR) is 15.9. Over the past 24 hours, the stock has changed by +2.25%. Follow the NVCR chart for real-time price dynamics.
What is the stock ticker of NovoCure Limited - Ordinary Shares?
NovoCure Limited - Ordinary Shares trades under the ticker NVCR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NovoCure Limited - Ordinary Shares stock going up?
NVCR has changed by -9.97% over the last week, -9.66% over the last month, and +15.64% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was NovoCure Limited - Ordinary Shares net income for the last quarter?
NovoCure Limited - Ordinary Shares reported net income of -71.14 M for the last quarter. The previous quarter showed -24.5 M, which means net income changed by -190.37%.
How many employees does NovoCure Limited - Ordinary Shares have?
As of the latest available data, NovoCure Limited - Ordinary Shares has 1 605 employees. Workforce size can provide additional context about the company's scale and operations.
What is NovoCure Limited - Ordinary Shares EBITDA?
NovoCure Limited - Ordinary Shares EBITDA is -70.04 M, and its EBITDA margin is -40.24%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NovoCure Limited - Ordinary Shares stock?
You can buy NovoCure Limited - Ordinary Shares (NVCR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NovoCure Limited - Ordinary Shares stock?
Investing in NovoCure Limited - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVCR chart and related analysis on metatrader.com as part of your research.